Earnings · China A-shares
Anhui Wanbang Pharmaceutical Technology Co., Ltd. Class A (301520) earnings
Anhui Wanbang Pharmaceutical Technology Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -98.27% year on year, -293.37% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +15.10% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -98.27%
- Excl. one-offs YoY
- -293.37%
- Net profit QoQ
- +8.65%
- Result
- Bad / loss
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +20.00% | — |
| 3 days | +15.10% | — |
| 7 days | +22.30% | — |
| 14 days | +2.08% | — |
Report history
Over the last 8 reports, net profit grew year on year in 0 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -2.43%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥572.35K | -98.27% | — | -12.03% | 0.01 | 0.04% | +15.10% | — | — |
| 2026 interim report | 2026-08-29 | ¥137.99K | -99.49% | — | -40.24% | 0.00 | 0.01% | -16.61% | -15.62% | -6.29% |
| 2026 Q1 report | 2026-04-23 | -¥261.78K | -102.21% | — | -57.02% | 0.00 | -0.02% | -3.71% | -19.59% | -18.03% |
| 2025 annual report | 2026-04-23 | ¥36.43M | -57.40% | -83.99% | -27.67% | 0.55 | 2.43% | -3.71% | -19.59% | -18.03% |
| 2025 Q3 report | 2025-10-23 | ¥33.11M | -57.44% | -84.89% | -28.60% | 0.50 | 2.21% | +2.27% | -2.39% | -1.52% |
| 2025 interim report | 2025-08-26 | ¥26.81M | -51.28% | -70.17% | -21.57% | 0.40 | 1.79% | -7.09% | -12.57% | -14.25% |
| 2025 Q1 report | 2025-04-22 | ¥11.85M | -60.09% | -76.44% | -21.20% | 0.18 | 0.78% | -4.56% | +6.42% | +3.55% |
| 2024 annual report | 2025-04-22 | ¥85.53M | -20.87% | -42.90% | +10.91% | 1.28 | 5.68% | -4.56% | +6.42% | +3.55% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.